France CT Scan Market Analysis

France CT Scan Market Analysis


$ 3999

France CT Scan Market was valued at $126.78 Mn in 2023 and is predicted to grow at a CAGR of 6.87% from 2023 to 2030, to $201.85 Mn by 2030. The key drivers of this industry include the rising burden of chronic diseases, expanding healthcare infrastructure, and the aging population. The industry is primarily dominated by GE HealthCare, Siemens Healthineers, Canon Medical Systems, and NeuroLogica Corp. among others.

ID: IN10FRMD022 CATEGORY: Medical Devices GEOGRAPHY: France AUTHOR: Sarita Yadav

Buy Now

France CT Scan Market Executive Summary

France CT Scan Market was valued at $126.78 Mn in 2023 and is predicted to grow at a CAGR of 6.87% from 2023 to 2030, to $201.85 Mn by 2030.  

A CT scan, or computed tomography scan, is a sophisticated imaging procedure that uses X-rays to produce detailed cross-sectional images of the body. Unlike traditional X-rays, CT scans capture multiple views from various angles, which a computer then processes into a three-dimensional representation of internal structures such as organs, bones, and soft tissues. Before the scan, patients may prepare by wearing a gown and removing metal objects. Depending on the type of scan, they might need to ingest a contrast material to enhance the visibility of specific tissues. During the scan, patients lie on a table that moves through a donut-shaped scanner while X-ray images are taken. Afterward, a radiologist interprets the images to diagnose conditions like cancer, heart disease, bone fractures, internal bleeding, and injuries. While CT scans offer detailed diagnostic capabilities, they involve radiation exposure and can be costly, though advancements have minimized risks and enhanced safety. Other imaging options like X-rays, ultrasound, and MRI scans are considered based on specific medical needs and radiation concerns.

Chronic kidney disease (CKD) in France affects 1.5% to 2.1% of adults aged 18-74 years, with a higher prevalence in women and older adults, reaching up to 9.9% in those aged 65-74 years. During the COVID-19 pandemic, chest CT scans played a crucial role in diagnosing COVID-19 pneumonia, especially when RT-PCR testing was unavailable or delayed, showing high sensitivity (87%) and specificity (85%), with a negative predictive value of 97%. From March 2020 to January 2021, 19% of 100,018 CT scans in France were conducted using the COVID-19 workflow.

The market therefore is driven by significant factors like the rising burden of chronic diseases, expanding healthcare infrastructure, and the aging population. However, high costs, regulations, and reimbursement, and radiation exposure concerns restrict the growth and potential of the market.

A prominent player in this field is GE Healthcare, which launched a new refurbishing unit in Bangladesh for A1-Sure Ultrasound Systems, aiming to enhance accessibility to affordable ultrasound technology in developing regions, and Siemens Healthineers partnered with Microsoft to utilize Azure cloud services for AI-powered medical imaging solutions, aimed at advancing healthcare delivery with secure and scalable cloud computing. Other contributors include Canon Medical Systems, and NeuroLogica Corp. among others.

France CT Scan Market Report 2023 to 2030

Market Dynamics

Market Growth Drivers

Rising Burden of Chronic Diseases: France is experiencing a growing prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders. CT scans are essential for the diagnosis, treatment, and monitoring of these conditions. According to the French Public Health Agency (Santé Publique France), chronic diseases account for over two-thirds of deaths in France.

Expanding Healthcare Infrastructure: Investments in both public and private healthcare facilities are enhancing the availability of CT scanners across France. This trend is expected to continue, thereby improving access to diagnostic imaging services for a larger segment of the population.

Aging Population: The demographic shift towards an aging population in France is increasing the demand for CT scans. The French National Institute of Statistics and Economic Studies (INSEE) projects that by 2050, over 30% of the French population will be 65 or older, a group that is more susceptible to medical conditions requiring CT imaging.

Market Restraints

High Costs: The cost of CT scans can be a significant barrier for some patients, especially those without adequate health insurance. The cost varies depending on the type of scan, use of contrast material, and facility fees, with industry reports suggesting a range between $580 - $1,750 per scan.

Regulations and Reimbursement: Strict regulations and potentially complex reimbursement procedures can create administrative burdens for healthcare providers, which may impact the utilization of CT scans.

Radiation Exposure Concerns: Despite advancements in reducing radiation doses, there remains a small risk associated with CT scans. This risk might prompt healthcare providers and patients to be cautious and refrain from undergoing unnecessary CT scans.

Regulatory Landscape and Reimbursement Scenario

The French CT scan market is regulated by the ANSM (Agence nationale de sécurité du médicament et des produits de santé), which requires manufacturers to obtain marketing authorization for new CT scanner models before they can be sold or used in France. The regulations are aligned with European Union Medical Device Regulations (MDR), ensuring safety, performance, and quality standards for CT scanners. Additionally, strict radiation protection regulations are in place to minimize unnecessary radiation doses to patients, and professional medical societies establish clinical practice guidelines to guide the appropriate use of CT scans.

Reimbursement for CT scans in France is managed by the national health insurance system, Assurance Maladie, which covers medically necessary CT scans for French citizens and residents. The government sets fixed reimbursement rates based on a national fee schedule, and physicians typically receive direct reimbursement from the health insurance system. In some cases, prior authorization may be required to ensure the scan meets medical necessity criteria, helping to control healthcare spending and maintain the efficient use of resources.

Competitive Landscape

Key Players

Here are some of the major key players in the France CT Scan Market:

  • GE HealthCare
  • Koninklijke Philips N.V.
  • Siemens Healthineers AG
  • Canon Medical Systems
  • NeuroLogica Corp.
  • Shanghai United Imaging Healthcare Co., Ltd.
  • Fujifilm Holdings Corporation
  • Shenzhen Anke High-tech Co., Ltd.
  • Koning Health
  • Carestream Dental LLC.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

France CT Scan Market Segmentation

By Technology

  • High-end Slice CT
  • Mid-end Slice CT
  • Low-end Slice CT
  • Cone Beam CT (CBCT)

By Application

  • Oncology
  • Cardiology
  • Vascular
  • Neurology
  • Musculoskeletal
  • Others

By Modality

  • O-Arms
  • C- Arms

By End-User

  • Hospitals
  • Diagnostic Imaging Centers
  • Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.​

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

  • Analyzing historical proprietary data collected from multiple projects.
  • Regularly updating our existing data sets with new findings and trends.
  • Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

  • Searching through academic conferences, published research, citations, and social media platforms
  • Collecting and compiling diverse data to build a comprehensive and detailed database
  • Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

  • Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
  • Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
  • Continuously refreshing our database to ensure that the information remains current and reliable.
  • Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

  • Merging historical data from secondary research with real-time data from primary research.
  • Conducting thorough data validation and cleansing to remove inconsistencies and errors.
  • Organizing data into a structured format that is easily accessible and usable for various applications.
  • Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


Last updated on: 23 July 2024
Updated by: Anish Swaminathan

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up